CTOs on the Move

Advarra

www.advarra.com

 
Advarra advances the way clinical research is conducted: bringing life sciences companies, CROs, research sites, investigators, and academia together at the intersection of safety, technology, and collaboration. With trusted IRB and IBC review solutions, innovative technologies, experienced consultants, and deep-seated connections across the industry, Advarra provides integrated solutions that safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance. Advarra is advancing clinical trials to make them safer, smarter, and faster.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.advarra.com
  • 6100 Merriweather Drive Suite 600
    Columbia, MD USA 21044
  • Phone: 410.884.2900

Executives

Name Title Contact Details
Jeff Sidell
 Chief Technology Officer Profile
Eric Whitford
 IT Director Profile
Nitin Uplekar
 Chief Information Officer Profile
Jonathan Shough
 President of Technology Solutions Profile

Jobs

VP, Chief Information Security Officer

Advarra Wellesley, MA

Similar Companies

NOXXON Pharma

Noxxon Pharma AG is a Germany-based biotechnology company with focus on cancer treatment. The Company develops drugs under the trademark Spiegelmer, which target the tumor microenvironment. Spiegelmers can be manufactured chemically and are a variant o...

Sleep Prescription

Sleep Prescription is a Rancho Santa Margarita, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Global Animal Management

Global Animal Management is a Union, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Adjuvants Plus Inc

Adjuvants Plus Inc is a Kingsville, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Clinical ink

Clinical ink is the global life science company that brings data, technology, and patient-centric research together. Our deep therapeutic-area expertise, coupled with Direct Data Capture, eCOA, eConsent, telehealth, neurocognitive testing, and digital biomarkers advancements, drive the industry standard for data precision and usher in a new generation of clinical trials. By harnessing digital data, we power sponsors, CROs, researchers, and patients to recenter decentralized trials and rewrite the clinical development experience.